Fig. 4: Activity of bZIP and bHLH transcription factors during skin Treg cell development is associated with binding site hypomethylation.

a, Enrichment of bZIP motifs in DMRs and differential peaks between skin Treg cells and blood CD45RA+ Treg cells (blood RA+ Treg cells). P values were determined by one-tailed binomial test implemented in homer31 (n = 1,742 DMRs, 298,457 DMRs, 5,722 peaks and 3,192 peaks for columns 1–4) with a Benjamini–Hochberg correction. b, Chromatin accessibility in skin Treg and blood CD45RA+ Treg cells (four donors, ATAC Donors 1, 2, 4 and 5) around genomic sites for a selected bZIP motif. c, Enrichment of bHLH motif sites in DMRs and differential peaks between skin Treg cells and blood CD45RA+ Treg cells. P values were determined as in a. d, Chromatin accessibility in skin Treg and blood CD45RA+ Treg cells around genomic sites for a selected bHLH motif. Donors are as in b. e, Transcriptomic footprint of transcription factors (that is, enrichment of target genes) among genes differentially expressed between skin Treg and blood CD45RA+ Treg cells. Labels correspond to transcription factor gene names. P values were determined by two-tailed permutation test (n = 28,078 genes) with a Benjamini–Hochberg correction. f, Expression of transcription factor genes corresponding to relevant motifs (mean ± s.d.; n = 4 skin Treg cell donors and 5 blood CD45RA+ Treg cell donors, Tissue Donors 7, 8, 10 and 11 and Blood Donors 3–5, 9 and 10). g, Methylation (top left, Tissue Donors 7, 10 and 11 and Blood Donors 3–5) and chromatin accessibility (middle left, ATAC Donors 1, 2, 4 and 5) in skin Treg and blood CD45RA+ Treg cells together with c-Myc ChIP–seq signal32 from three cell lines (bottom left) around c-Myc motif sites associated with MLPH and GNA11 and quantitative PCR with reverse transcription showing relative gene expression (mean) of MLPH (guide RNA A or B) and GNA11 in primary blood Treg cells from six donors (CRISPR Donors 1–6, three donors per guide RNA) after CRISPR-mediated activation originating from regions shown in track plots (right). Highlighted regions correspond to selected DMRs (methylation tracks), scATAC-seq peaks (chromatin accessibility tracks) and c-Myc motif sites (motif ± 100 bases; ChIP–seq and gene tracks). Vertical lines at the bottom of the methylation tracks mark CpG sites. P values were determined by two-tailed paired t-test (n = 3 donors). Data are representative of two or more independent experiments with two or more individual donors.